Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayank Dalakoti

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
European Heart Journal|September 7, 2023
Redirecting immune, lipid, and metabolic drivers of early cardiovascular disease: the RESET cohort study and randomized trialMayank Dalakoti, Roger Foo,
European Journal of Preventive Cardiology|June 24, 2024
Incremental progress but still far from good enough: real-world LDL-cholesterol insights from the SANTORINI 1-year follow-up studyMayank Dalakoti, Denis Angoulvant
American Journal of Preventive Cardiology|September 10, 2024
Lifelong prevention of atherosclerotic cardiovascular disease (ASCVD) through LDL-C control - Means and cost/benefit of sustained very low lifetime LDL-C targetsMayank Dalakoti, Salim Virani
The Lancet Regional Health. Western Pacific|August 28, 2023
Healthier SG - throwing down the gauntlet for specialists to integrateMayank Dalakoti, Roger Foo
European Journal of Internal Medicine|October 23, 2024
Treat the patient, not the disease: The embolic stroke of undetermined source as an opportunity to optimize cardiovascular prevention in a holistic approachGeorge Ntaios, Mayank Dalakoti
European Journal of Preventive Cardiology|April 29, 2026
Primordial Prevention of Cardiovascular Disease: From Mirage to MissionMayank Dalakoti, Rodrigo Fernández-Jiménez
European Journal of Preventive Cardiology|June 2, 2026
Prevention, mentorship, and meaning: an interview with Professor Emeline Van CraenenbroeckMayank Dalakoti, Emeline Van Craenenbroeck
The Lancet Regional Health. Western Pacific|August 5, 2024
Unveiling the black box: imperative for explainable AI in cardiovascular disease (CVD) prevention-author replyMayank Dalakoti, Scott Wong, Roger Foo
Cardiovascular Research|June 11, 2024
How far are we from accurate sex-specific risk prediction of cardiovascular disease? One size may not fit allBi Huang, Mayank Dalakoti, Gregory Y H Lip
Journal of Hepatology|February 20, 2026
Cardiovascular Risk in MASLD: What Multiple Lines of Evidence RevealNaveed Sattar, Mayank Dalakoti, William Alazawi, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
European Heart Journal|September 7, 2023
Redirecting immune, lipid, and metabolic drivers of early cardiovascular disease: the RESET cohort study and randomized trialMayank Dalakoti, Roger Foo,
European Journal of Preventive Cardiology|June 24, 2024
Incremental progress but still far from good enough: real-world LDL-cholesterol insights from the SANTORINI 1-year follow-up studyMayank Dalakoti, Denis Angoulvant
American Journal of Preventive Cardiology|September 10, 2024
Lifelong prevention of atherosclerotic cardiovascular disease (ASCVD) through LDL-C control - Means and cost/benefit of sustained very low lifetime LDL-C targetsMayank Dalakoti, Salim Virani
The Lancet Regional Health. Western Pacific|August 28, 2023
Healthier SG - throwing down the gauntlet for specialists to integrateMayank Dalakoti, Roger Foo
European Journal of Internal Medicine|October 23, 2024
Treat the patient, not the disease: The embolic stroke of undetermined source as an opportunity to optimize cardiovascular prevention in a holistic approachGeorge Ntaios, Mayank Dalakoti
European Journal of Preventive Cardiology|April 29, 2026
Primordial Prevention of Cardiovascular Disease: From Mirage to MissionMayank Dalakoti, Rodrigo Fernández-Jiménez
European Journal of Preventive Cardiology|June 2, 2026
Prevention, mentorship, and meaning: an interview with Professor Emeline Van CraenenbroeckMayank Dalakoti, Emeline Van Craenenbroeck
The Lancet Regional Health. Western Pacific|August 5, 2024
Unveiling the black box: imperative for explainable AI in cardiovascular disease (CVD) prevention-author replyMayank Dalakoti, Scott Wong, Roger Foo
Cardiovascular Research|June 11, 2024
How far are we from accurate sex-specific risk prediction of cardiovascular disease? One size may not fit allBi Huang, Mayank Dalakoti, Gregory Y H Lip
Journal of Hepatology|February 20, 2026
Cardiovascular Risk in MASLD: What Multiple Lines of Evidence RevealNaveed Sattar, Mayank Dalakoti, William Alazawi, et al.
Pageof 7